| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$11 |
Shareholder update webinar
|
31 Oct 2025 9:20AM |
$0.012 |
$0.007 |
fallen by
41.67%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$68 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:19AM |
$0.012 |
$0.021 |
risen by
75%
|
|
CLA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for period ending 30 September 2025.
- MCB Project advancing with ongoing feasibility and engineering studies.
- Financial support from Maharlika Investment Corporation.
- Closing cash balance of A$2.39 million as of the end of the quarter.
- Community and environmental management efforts underway.
- Company actively engaging investors for further funding solutions.
- Significant assay results from drilling reaffirm project potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$446 |
Quarterly Activities and Cashflow Report
|
31 Oct 2025 9:19AM |
$0.145 |
$0.360 |
risen by
148.28%
|
|
GLN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of due diligence by Clean Elements Fund.
- RIGI incentive regime approval by Argentine Government.
- $20 million placement secured for Phase 1 construction.
- First lithium chloride production expected in H1 2026.
- Strong financial position with no debt and significant cash reserves.
- Strategic expansion in Greenbushes South tenure.
- Focus on the HMW lithium brine project development in Argentina.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peregrine Gold Ltd (PGD) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:19AM |
$0.220 |
$0.215 |
fallen by
2.27%
|
|
PGD - Price-sensitive ASX Announcement
Full Release
Key Points
- High grade CID targets identified at Coopers and Peninsula CID Prospects.
- Expansion of gold footprints at Tin Can and Epithermal Prospects.
- Successful $3.0m placement with major investors.
- Cash at bank of ~$4.3m at quarter end.
- Net cash used in operating activities: $1.338m.
- Net cash from investing activities: $1.926m.
- Net cash from financing activities: $2.758m.
- Exploration expenses totaled ~$1.2m for the quarter.
- Payments to related parties totaled $277,934.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,452 |
Update - Notification of buy-back - WHC
|
31 Oct 2025 9:19AM |
$7.220 |
$7.810 |
risen by
8.17%
|
|
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$582 |
Appendix 3Y - P. Mann
|
31 Oct 2025 9:19AM |
$2.470 |
$1.715 |
fallen by
30.57%
|
|
| Aspire Mining Limited (AKM) ORDINARY FULLY PAID |
Materials |
$142 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:19AM |
$0.250 |
$0.280 |
risen by
12%
|
|
AKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Ovoot Coking Coal Project holds JORC-compliant 219.4 million tonnes of resources.
- Aspire Mining has no outstanding debt and USD 9.4 million in cash.
- Murun-Uliastai Highway Project development endorsed by the Mongolian government.
- Aspire regains marketing rights over Ovoot and Nuurstei projects.
- Appointment of new Independent Non-Executive Directors to strengthen the board.
- Advancement in Ovoot site establishment and infrastructure for future construction.
- Investments in exploration and evaluation totaled USD 401k in the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$16 |
September Quarter Results Presentation
|
31 Oct 2025 9:18AM |
$0.035 |
$0.026 |
fallen by
25.71%
|
|
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$582 |
Appendix 3Y - K. Spargo
|
31 Oct 2025 9:17AM |
$2.470 |
$1.715 |
fallen by
30.57%
|
|
| Austral Gold Limited (AGD) ORDINARY FULLY PAID |
Materials |
$124 |
Austral Gold Files Q3 2025 Quarterly Activity Report
|
31 Oct 2025 9:17AM |
$0.079 |
$0.200 |
risen by
153.16%
|
|
AGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Production in Q3 2025 declined due to a temporary shutdown following a fatality.
- Guanaco operations produced 2,244 GEOs, a 22% decrease from Q2 2025.
- Operating cash cost increased to US$3,475 per GEO.
- All-in-sustaining cost rose to US$3,768 per GEO.
- Revised production guidance for 2025 is 11,000-12,000 GEOs.
- Both leaching circuits expected to be fully operational by November.
- Power outages and mechanical failures also impacted production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Desert Minerals Ltd (DSM) ORDINARY FULLY PAID |
Materials |
$7 |
Mt Monger Drilling Preparations Underway
|
31 Oct 2025 9:16AM |
$0.235 |
$0.280 |
risen by
19.15%
|
|
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$44 |
Update - Notification of buy-back - EPY
|
31 Oct 2025 9:16AM |
$0.210 |
$0.170 |
fallen by
19.05%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$33 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:16AM |
$0.280 |
$0.255 |
fallen by
8.93%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- Primary endpoint in Phase 2 AIS trial met; ARG-007 found safe and well tolerated.
- Efficacy signal observed in high-risk AIS patient subgroup.
- Cash reserves of $6.4 million as of 30 September 2025.
- Additional funding expected from R&D tax incentives and grants.
- Net operating cash outflows of $4.120 million for the quarter.
- Argenica plans to advance a targeted Phase 2b AIS trial.
- Received $0.258 million in non-dilutive grant funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$61 |
High Resolution Heli-Mag & Radiometrics Survey Commence
|
31 Oct 2025 9:15AM |
$0.335 |
$0.165 |
fallen by
50.75%
|
|
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$8 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:15AM |
$0.054 |
$0.026 |
fallen by
51.85%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- DXN Limited reported a cash balance of $2.4 million as of 30 September 2025.
- Q1 revenue was $0.94 million, down 68.8% from the prior corresponding period due to project deferrals.
- Net cash used in operating activities was $(428,000) for the September quarter.
- The company reported a total backlog of $11.9 million and expects revenue growth in FY26, especially in the second half.
- DXN's new Data Centre as a Service (DCaaS) division is expected to generate recurring revenue starting November 2026.
- The company is focusing on expanding its Asia-Pacific operations by enhancing sales and engineering capabilities.
- DXN has a secured loan facility of $5 million with iPartners, maturing in November 2026 at an interest rate of 9.95%.
- Payments to related parties amounted to $156,000 in the quarter.
- The company expects to continue operations based on its project-based business model and has no immediate plans to raise additional cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$9 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:15AM |
$0.026 |
$0.025 |
fallen by
3.85%
|
|
WC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling program commenced at Mystique Gold Project, targeting completion by October.
- Significant REE, TiO2, and scandium findings in Fraser Range.
- Evaluating REE and scandium extraction for Salazar Project.
- Preparing Bulla Park Deposit for expansion.
- Pursuing exposure in USA for critical minerals.
- Raised $1.25 million in equity placements.
- Ended the quarter with $0.6 million cash reserves.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4C and Quarterly Activities Report - September 2025
|
31 Oct 2025 9:14AM |
$0.089 |
$0.082 |
fallen by
7.87%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited received Orphan Drug Designation from the US FDA for its lead cancer drug INV043 to treat anal cancer, providing commercial and development benefits.
- A new collaboration agreement was established with Protect Animal Health Inc. to conduct studies using Photosoft for treating cancer in companion animals.
- Invion improved its balance sheet with the issuance of a $1M Loyalty Entitlement Offer and a $782K convertible note, enhancing financial flexibility.
- The company's Phase I/II non-melanoma skin cancer trial in Queensland continued, while preparations for an anogenital cancer trial with Peter MacCallum Cancer Centre are underway.
- Invion is in ongoing negotiations with RMW to expand its global licensing agreement for Photosoft technology.
- The company held cash reserves of $537K at the end of the September 2025 quarter.
- Invion's key cash outflows included administration, corporate costs, and R&D expenses.
- Invion raised funds through a convertible note issue, cornerstoned by biotech funds, with funds used to improve capital structure.
- Invion participated in AusBiotech events, highlighting new advancements in personalised therapies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$16 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:14AM |
$0.035 |
$0.026 |
fallen by
25.71%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive operating cash flow of $217,000.
- Net cash position of $3.565 million at the quarter's end.
- Significant group margin increase to 54% after exiting a low-margin service.
- AUDD stablecoin listed on Coinbase, marking a significant milestone.
- Strategic focus on revenue reform and growth leading to new commercial deals.
- Achieved positive EBITDA for the quarter.
- Commitment to long-term financial targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 360 Capital Group (TGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$59 |
Change of Director's Interest Notice
|
31 Oct 2025 9:14AM |
$0.315 |
$0.300 |
fallen by
4.76%
|
|
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$11 |
Cleansing Notice
|
31 Oct 2025 9:14AM |
$0.012 |
$0.007 |
fallen by
41.67%
|
|
| Prairie Lithium Limited (PL9) ORDINARY FULLY PAID |
Materials |
$39 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:14AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
PL9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Fast-tracked Prairie Lithium Project with DLE unit fabrication approved.
- Signed MOU with Long Creek Rail for market access.
- Completed name change from Arizona Lithium to Prairie Lithium.
- Secured US$5 Million from selling Big Sandy Lithium Project.
- Conducted strategic meetings with North American and Asian partners.
- Signed an offtake agreement with Stardust Power Inc. for LCE supply.
- Net increase in cash and cash equivalents reported at the end of the period.
- Appendix 5B detailed cash flow report provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xstate Resources Limited (XST) ORDINARY FULLY PAID |
Energy |
$9 |
Proposed issue of securities - XST
|
31 Oct 2025 9:13AM |
$0.022 |
$0.022 |
fallen by
0%
|
|
| Xstate Resources Limited (XST) ORDINARY FULLY PAID |
Energy |
$9 |
Proposed issue of securities - XST
|
31 Oct 2025 9:13AM |
$0.022 |
$0.022 |
fallen by
0%
|
|
| Xstate Resources Limited (XST) ORDINARY FULLY PAID |
Energy |
$9 |
$3.82m Raise to Advance Diona Appraisal and Production Test
|
31 Oct 2025 9:13AM |
$0.022 |
$0.022 |
fallen by
0%
|
|
XST - Price-sensitive ASX Announcement
Full Release
Key Points
- $3.82m was raised over a two-tranche placement.
- Funds will support Diona-1 production testing and further exploration.
- The Diona-1 Well reached a final Total Depth of 2,479m.
- Xstate Resources focuses on the oil and gas sector.
- Xstate owns 51% of ATP 2077.
- Elixir Energy Limited retains ownership in Blocks A and B.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$25 |
Trading Halt
|
31 Oct 2025 9:13AM |
$0.155 |
$0.115 |
fallen by
25.81%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Battery Age Minerals Ltd (ASX: BM8) has requested a trading halt.
- The trading halt is pending an announcement regarding a capital raise.
- The trading halt will remain until the start of trading on 4 November 2025 or upon the release of the announcement.
- The company is not aware of any reasons against the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
